Symptomatic thrombosis in central venous catheter in oncology: A predictive score?;Thrombose symptomatique sur cathéter veineux central de longue durée en oncologie: Un score de risque prédictif?

Revue de Medecine Interne

Volumn 26, Issue 4, 2005, Pages 273-279

  Morazin, F ^a   Kriegel, I ^a   Asselain, B ^a   Falcou, M C ^a  

^a INSTITUT CURIE   (France)

Author keywords

Cancer; Central venous catheters; Thrombosis

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOLOGY; PHLEBOGRAPHY; PREDICTION; RISK FACTOR; SOLID TUMOR; SUBCLAVIAN VEIN; SUPERIOR CAVA VEIN; ULTRASOUND SCANNER; VEIN THROMBOSIS;

EID: 17044410169     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.11.017     Document Type: Article

References (23)

1. K.H. Polderman, and A.R.J. Girbes Central venous catheter use Intensive Care Med. 28 2002 1 28
2. I.I. Raad, S. Davis, M. Becker, D. Hohn, D. Houston, and J. Umphrey Low infection rate and long durability of nontunneled silastic catheters Arch. Intern. Med. 153 1993 1791 1796
3. F. Bonnet, J.F. Loriferne, J.P. Texier, A. Salvat, and N. Vasile Evaluation of Doppler examination for diagnosis of catheter-related deep vein thrombosis Intensive Care Med. 15 1989 238 240
4. C. Koksoy, A. Kuzu, J. Kutlay, I. Erden, H. Ozcan, and K. Ergin The diagnostic value of color Doppler ultrasound in central venous catheter-related thrombosis Clin. Radiol. 50 1995 687 689 (a)
5. A. Luciani, O. Clement, P. Halimi, D. Goudot, F. Portier, and V. Bassot Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US Radiology 220 2001 655 660
6. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J. Amer. Statist. Assoc. 53 1958 457 481
7. D.R. Cox Regression models and life tables J. Roy Statistic. Soc. 34 1972 187 220
8. J.R. Gould, H.W. Carloss, and W.L. Skinner Groshong catheter-associated subclavian venous thrombosis Am. J. Med. 95 1993 419 423
9. B. Damascelli, G. Patelli, L.F. Frigerio, R. Lanocita, F. Garbagnati, and A. Marchiano Placement of long-term central venous catheters in outpatients: study of 134 patients over 24596 catheter days AJR Am. J. Roentgenol. 168 1997 1235 1239
10. R. Biffi, F. de Braud, F. Orsi, S. Pozzi, S. Mauri, and A. Goldhirsch Totally implantable central venous access ports for long-term chemotherapy. A Prospective study analysing complications and costs of 333 devices with a minimum follow-up of 180 days Ann. Oncol. 9 1998 767 773
11. S. MacDonald, A.J. Watt, D. McNally, R.D. Edwards, and J.G. Moss Comparison of technical success and outcome of tunnelled catheters inserted via the jugular and subclavian approaches J. Vasc. Interv. Radiol. 11 2000 225 231
12. rd, D.J. May, H.R. Alexander, E.P. Steinhaus, E.D. Whitman, and R.C. Chang Venographic surveillance of tunnelled venous access devices in adult oncology patients Ann. Surg. Oncol. 2 1995 174 178 (a)
13. A.K. Kakkar, and R.C. Williamson Thromboprophylaxis in the cancer patient Haemostasis Suppl 3 1998 61 65
14. M. Ratcliffe, C. Broadfoot, M. Davidson, K.F. Kelly, and M. Greaves Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombic prophylaxis using low-dose warfarin in subjects with malignant disease Clin. Lab. Haematol. 21 1999 353 357
15. L. Drouet Pathologie thromboembolique veineuse. Nouveaux facteurs de risque acquis ou nouvelles donńes sur les facteurs de risque acquis Arch. Mal. Coeur Vaiss. 94 2001 1318 1326
16. M.N. Levine, M. Gent, J. Hirsch, A. Arnold, M.D. Goodyear, W. Hryniuk, and S. DE Pauw The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer N. Engl. J. Med. 318 1988 404 407
17. T. Saphner, D.C. Torney, and R. Gray Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer J. Clin. Oncol. 9 1991 286 294
18. L. Orlando, M. Colleoni, F. Nole, R. Biffi, A. Rocca, and G. Curigliano Incidence of venous thromboembolism in brest cancer patients undergoing chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required? Ann. Oncol. 11 2000 117 118
19. J.D. Kooij, F.M. Van der Zant, E.J. Van Beek, and J.A. Reekers Pulmonary embolism in deep venous thrombosis of the upper extremity: more often in catheter-related thrombosis Neth. J. Med. 50 1997 238 242
20. M.M. Bern, J.J. Lokich, S.R. Wallach, A. Bothe Jr., P.N. Benotti, and C.F. Arkin Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomised prospective trial Ann. Intern. Med. 112 1990 423 428
21. V. Puel, M. Caudry, P. Le Metayer, J.C. Baste, D. Midy, and C. Marsault Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports Cancer 72 1993 2248 2252
22. G.V. Stanislas, R.J. Fitzgibbons, R.T. Bailey, J.A. Maillard, S. Johson, and F.B. Feole Reliability of implantable central venous access devices in patients with cancer Arch. Surg. 122 1987 1280 1283
23. J. Petersen, J.H. Delaney, M.T. Brakstad, R.K. Rowbotham, and C.M. Bagley Jr. Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction Am. J. Surg. 178 1999 38 41